Georgia Keresty's Insider Trades & SAST Disclosures
Georgia Keresty's most recent trade in Intellia Therapeutics Inc was a trade of 11,515 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Georgia Keresty.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 23,883 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 16,146 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 11,721 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 3,465 | 0 (0%) | 0% | - | Common Stock | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,684 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,531 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,444 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 303 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 826 | 3,465 (0%) | 0% | 0 | Common Stock | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,531 | 1,531 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 866 | 2,639 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 3,382 | 3,382 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 2,094 | 2,094 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2021 | 7,755 | 7,755 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2021 | 4,955 | 4,955 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2020 | 303 | 303 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2020 | 154 | 1,773 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges